American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome

Am J Gastroenterol. 2018 Jun;113(Suppl 2):1-18. doi: 10.1038/s41395-018-0084-x.

Authors

Alexander C Ford¹, Paul Moayyedi², William D Chey³, Lucinda A Harris⁴, Brian E Lacy⁵, Yuri A Saito⁶, Eamonn M M Quigley⁷; ACG Task Force on Management of Irritable Bowel Syndrome

Affiliations

¹ Leeds Institute of Biomedical and Clinical Sciences, University of Leeds and Leeds Gastroenterology Institute, Leeds Teaching Hospitals Trust, Leeds, UK.
² Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
³ Division of Gastroenterology, Department of Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
⁴ Mayo Clinic, Scottsdale, AZ, USA.
⁵ Mayo Clinic, Jacksonville, FL, USA.
⁶ Mayo Clinic, Rochester, MN, USA.
⁷ Division of Gastroenterology and Hepatology, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX, USA. equigley@houstonmethodist.org.

PMID: 29950604
DOI: 10.1038/s41395-018-0084-x

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't
Systematic Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antidepressive Agents / therapeutic use
Behavior Therapy
Constipation / drug therapy*
Diarrhea / drug therapy*
Diet
Dietary Fiber / administration & dosage
Dietary Fiber / adverse effects
Dietary Supplements*
Exercise
Humans
Irritable Bowel Syndrome / therapy*
Mentha piperita
Parasympatholytics / therapeutic use
Plant Oils / therapeutic use
Prebiotics
Probiotics / therapeutic use
Randomized Controlled Trials as Topic
Synbiotics

Substances

Anti-Bacterial Agents
Antidepressive Agents
Dietary Fiber
Parasympatholytics
Plant Oils
Prebiotics
peppermint oil

Grants and funding

Canadian Institute for Health Research/International